Viveve Medical Valuation
| VIVE Stock | USD 0.0002 0.00 0.00% |
Viveve Medical seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Viveve Medical from inspecting the company fundamentals such as Return On Equity of -2.11, shares owned by institutions of 5.21 %, and Current Valuation of 4.26 M as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Viveve Medical's price fluctuation is out of control at this time. Calculation of the real value of Viveve Medical is based on 3 months time horizon. Increasing Viveve Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Viveve pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Viveve Medical. Since Viveve Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Viveve Pink Sheet. However, Viveve Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.0E-4 | Real 1.92E-4 | Hype 1.93E-4 | Naive 2.16E-4 |
The real value of Viveve Pink Sheet, also known as its intrinsic value, is the underlying worth of Viveve Medical Company, which is reflected in its stock price. It is based on Viveve Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Viveve Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Viveve Medical helps investors to forecast how Viveve pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Viveve Medical more accurately as focusing exclusively on Viveve Medical's fundamentals will not take into account other important factors: About Viveve Medical Valuation
The pink sheet valuation mechanism determines Viveve Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Viveve Medical. We calculate exposure to Viveve Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Viveve Medical's related companies.Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado. Viveve Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 47 people.
8 Steps to conduct Viveve Medical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Viveve Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Viveve Medical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Viveve Medical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Viveve Medical's revenue streams: Identify Viveve Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Viveve Medical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Viveve Medical's growth potential: Evaluate Viveve Medical's management, business model, and growth potential.
- Determine Viveve Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Viveve Medical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Viveve Medical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Viveve Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 10.1 M | |
| Retained Earnings | -241.9 M |
Complementary Tools for Viveve Pink Sheet analysis
When running Viveve Medical's price analysis, check to measure Viveve Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viveve Medical is operating at the current time. Most of Viveve Medical's value examination focuses on studying past and present price action to predict the probability of Viveve Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viveve Medical's price. Additionally, you may evaluate how the addition of Viveve Medical to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |